Work Here?
About Nomic
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Overview
Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.
Simplify's Take
What believers are saying
- Omni 1000 democratizes proteome-wide profiling for drug discovery and biomarker validation.[5]
- $42M Series B September 2024 funds commercial expansion amid rising demand.[5]
- Context-specific ~300-protein panels enable targeted discovery without multiplexing limitations.[2]
What critics are saying
- Olink's Explore HT delivers 6000+ proteins, capturing larger pharma budgets.[1]
- SomaScan's 11,000-protein aptamer technology erodes biomarker discovery market share.[1]
- Post-Series B cash burn exceeds revenue as manufacturing scales in 2026.[1]
What makes Nomic unique
- nELISA technology enables 1000-plex protein measurement at $50 per sample affordably.[5]
- DNA-barcoded beads decode protein identity on standard flow cytometers seamlessly.[3]
- End-to-end service model compatible with existing lab workflows and automation.[4]
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$60.1M
Above
Industry Average
Funded Over
4 Rounds
Y CombinatorIndustry standards
Benefits
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 4%2 year growth
↑ 1%MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.
Y Combinator’s Demo Day was a bit different this time around.
Nomic is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Nomic
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$60.1M
Headquarters
Montreal, Canada
Founded
2017
Nomic is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today